A simple, safe, one-a-day capsule of omega-3 polyunsaturated fatty acids (PUFA) can reduce mortality and admission to hospital for cardiovascular reasons in patients with heart failure. These are the conclusions of the first of two Articles based on the GISSI-HF* study published early
Online and in an upcoming edition of The Lancet. The moment spread concludes that statin treatment with rosuvastatin does not affect clinical outcomes in patients with chronic heart failure.Original post by Women’s Health / Gynecology News From Medical News Today